Tag Archives: NTEC

Top China Stocks To Buy For 2019

Where should I put my money now if I believe the stock market is going to crash?—Jerry, Virginia

If you really believe the market is headed for an imminent crash, there are all sorts of places you could invest your money. You could move it all into cash, you could buy gold or real estate or for that matter you could even take an aggressive approach and try to capitalize on stocks’ carnage by loading up on investments designed to rise when the market falls, such as bear market funds or put options.

But do I think you should actually do any of these things? No. And the reason is that there’s a big difference between believing and knowing.

I can understand why someone would conclude from the market’s recent setbacks and crazy whiplash volatility that all this turmoil is a prelude to a major meltdown. And for all I or anyone else knows, that may be the case.

Or it may not be. Think about it. Doomsayers have pointed to any number of reasons in recent years why they believed the market was headed for a downturn: Standard & Poor’s downgrading of U.S. Treasury debt in 2011; the growth-slowdown scare in China that sent stock prices down 12% in the summer of 2015; Brexit and the election of Donald Trump, both of which were supposed to be catalysts for a market rout. But none of these warnings panned out.

Top China Stocks To Buy For 2019: Woori Bank(WF)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Wells Fargo (WF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    News headlines about Woori Bank (NYSE:WF) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Woori Bank earned a news sentiment score of 0.19 on Accern’s scale. Accern also assigned press coverage about the bank an impact score of 46.2147954877183 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Stephan Byrd]

    Woori Bank (NYSE:WF) and ANZ (OTCMKTS:ANZBY) are both large-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

Top China Stocks To Buy For 2019: Intec Pharma Ltd.(NTEC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Intec Pharma (NTEC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Intec Pharma (NASDAQ:NTEC) has been assigned a $15.00 target price by Oppenheimer in a research note issued to investors on Wednesday. The firm presently has a “buy” rating on the biotechnology company’s stock. Oppenheimer’s price objective would indicate a potential upside of 185.71% from the company’s current price.

  • [By Ethan Ryder]

    Media stories about Intec Pharma (NASDAQ:NTEC) have been trending somewhat positive on Wednesday, according to Accern Sentiment. The research group ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Intec Pharma earned a coverage optimism score of 0.18 on Accern’s scale. Accern also assigned news stories about the biotechnology company an impact score of 45.6707447165993 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Intec Pharma (NTEC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Headlines about Intec Pharma (NASDAQ:NTEC) have trended somewhat positive recently, Accern Sentiment reports. Accern scores the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Intec Pharma earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news coverage about the biotechnology company an impact score of 45.4513319646459 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Ethan Ryder]

    Intec Pharma Ltd (NASDAQ:NTEC) – Analysts at Oppenheimer decreased their FY2019 EPS estimates for Intec Pharma in a research note issued to investors on Monday, March 4th. Oppenheimer analyst J. Olson now expects that the biotechnology company will post earnings of ($1.18) per share for the year, down from their previous forecast of ($1.04). Oppenheimer has a “Buy” rating and a $15.00 price objective on the stock. Oppenheimer also issued estimates for Intec Pharma’s FY2020 earnings at ($1.19) EPS, FY2021 earnings at ($1.56) EPS, FY2022 earnings at $0.28 EPS and FY2023 earnings at $1.18 EPS.

Top China Stocks To Buy For 2019: tronc, Inc. (TRNC)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Shares of newspaper company Tronc Inc. (NASDAQ: TRNC) rose on a rumored buyout. According to The New York Post:

    Tronc shares shot up again on Thursday with the news that the private equity firm Donerail Group is the company that is eyeing the owner of the Chicago Tribune, New York Daily News, Baltimore Sun and other papers for a takeover.

  • [By Douglas A. McIntyre]

    Lewis D’Vorkin, the editor-in-chief of the L.A. Times, owned by Tronc Inc. (NASDAQ: TRNC), left the paper after contentious relations with his staff. According to The Wall Street Journal:

  • [By Elizabeth Balboa]

    Lee Enterprises, Incorporated (NYSE: LEE), tronc Inc (NASDAQ: TRNC) and A&E Networks — a subsidiary of Walt Disney Co (NYSE: DIS) — were found to have forgone the costly risk of violating GDPR and pulled out of the European market altogether.

  • [By Douglas A. McIntyre]

    Several large newspaper chains will face the largest increases in newsprint prices in absolute dollars. These are Gannett (NYSE: GCI), tronc (NASDAQ: TRNC), hedge fund owned Digital First Media, which just laid off dozens of people in Denver and on the West Coast, Hearst, Advance Media, McClatchy (NYSE: MNI) and Gatehouse Media. Among them, they own most of the large newspapers in America and hundreds of newspapers in aggregate. Each of these companies has newsprint demand much larger than that of The Tampa Bay Times.

  • [By Douglas A. McIntyre]

    An arrangement for the largest shareholder of publisher Tronc Inc. (NASDAQ: TRNC) to sell his stock will not go through. According to The Wall Street Journal:

Top Performing Stocks To Own For 2019

Millionaires Love These 10 Small Towns

Top 10 Best Performing ESG Funds of 2017: Morningstar

5 Worst States for Insurance Producer Fines

House lawmakers plan to convene a hearing Thursday to discuss the impact of the Department of Labor’s fiduciary rule on the capital markets. The hearing will focus on a draft bill put forth by Rep. Ann Wagner, R.-Mo., that seeks to kill the fiduciary rule and instead impose a best interest standard on broker-dealers’ investment recommendations.

The Consumer Federation of America sent a letter Tuesday to members of the committee expressing “strong opposition” to the measure, stating that it “would dramatically weaken existing protections for retirement savers without providing meaningful new protections for investors in non-retirement accounts.”

A Morningstar regulatory specialist says changes to enforcement and even a delay in the full rollout date are possible.

You are signed up!

Top Performing Stocks To Own For 2019: THL Credit, Inc.(TCRD)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on THL Credit (TCRD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    THL Credit, Inc. (NASDAQ:TCRD) CFO Terrence W. Olson purchased 11,511 shares of the firm’s stock in a transaction on Friday, May 11th. The stock was bought at an average price of $7.86 per share, for a total transaction of $90,476.46. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website.

  • [By Max Byerly]

    Thl Credit (NASDAQ: TCRD) and Tian Ge Interactiv (OTCMKTS:TGRVF) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, profitability, risk, institutional ownership and valuation.

  • [By Shane Hupp]

    THL Credit (NASDAQ: TCRD) and Safeguard Scientifics (NYSE:SFE) are both small-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, valuation, risk, analyst recommendations and dividends.

  • [By Max Byerly]

    THL Credit, Inc. (NASDAQ:TCRD) CFO Terrence W. Olson acquired 10,200 shares of the business’s stock in a transaction on Wednesday, May 9th. The stock was acquired at an average price of $7.80 per share, for a total transaction of $79,560.00. The acquisition was disclosed in a document filed with the SEC, which is available at this link.

  • [By Logan Wallace]

    THL Credit, Inc. (NASDAQ:TCRD) CFO Terrence W. Olson acquired 8,036 shares of the stock in a transaction on Monday, June 4th. The shares were acquired at an average cost of $7.92 per share, for a total transaction of $63,645.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Top Performing Stocks To Own For 2019: HomeTrust Bancshares, Inc.(HTBI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Hometrust Bancshares (NASDAQ: HTBI) and TFS Financial (NASDAQ:TFSL) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends.

  • [By Shane Hupp]

    Headlines about Hometrust Bancshares (NASDAQ:HTBI) have trended somewhat positive on Saturday, according to Accern. The research firm identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Hometrust Bancshares earned a media sentiment score of 0.20 on Accern’s scale. Accern also gave news coverage about the financial services provider an impact score of 46.8198551712188 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Stephan Byrd]

    Hometrust Bancshares (NASDAQ:HTBI) and Dime Community Bancshares (NASDAQ:DCOM) are both small-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, dividends and analyst recommendations.

  • [By Joseph Griffin]

    Northrim BanCorp (NASDAQ: NRIM) and Hometrust Bancshares (NASDAQ:HTBI) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

Top Performing Stocks To Own For 2019: Intec Pharma Ltd.(NTEC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Intec Pharma (NASDAQ:NTEC) has been assigned a $15.00 target price by Oppenheimer in a research note issued to investors on Wednesday. The firm presently has a “buy” rating on the biotechnology company’s stock. Oppenheimer’s price objective would indicate a potential upside of 185.71% from the company’s current price.

  • [By Ethan Ryder]

    Media stories about Intec Pharma (NASDAQ:NTEC) have been trending somewhat positive on Wednesday, according to Accern Sentiment. The research group ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Intec Pharma earned a coverage optimism score of 0.18 on Accern’s scale. Accern also assigned news stories about the biotechnology company an impact score of 45.6707447165993 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Max Byerly]

    Headlines about Intec Pharma (NASDAQ:NTEC) have trended somewhat positive recently, Accern Sentiment reports. Accern scores the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Intec Pharma earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news coverage about the biotechnology company an impact score of 45.4513319646459 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Intec Pharma (NTEC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Intec Pharma (NTEC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Performing Stocks To Own For 2019: Platform Specialty Products Corporation(PAH)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Platform Specialty Products (PAH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Cubist Systematic Strategies LLC acquired a new position in Platform Specialty Products Corp (NYSE:PAH) in the second quarter, Holdings Channel reports. The fund acquired 39,513 shares of the specialty chemicals company’s stock, valued at approximately $458,000.

  • [By Stephan Byrd]

    Shares of Platform Specialty Products Co. (NYSE:PAH) have earned a consensus rating of “Hold” from the eight brokerages that are presently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $14.40.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Platform Specialty Products (PAH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Victory Capital Management Inc. decreased its stake in Platform Specialty Products Corp (NYSE:PAH) by 0.2% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 3,692,379 shares of the specialty chemicals company’s stock after selling 8,086 shares during the period. Victory Capital Management Inc.’s holdings in Platform Specialty Products were worth $42,832,000 at the end of the most recent quarter.

Top 10 Stocks To Own For 2019

HubSpot, Inc. (NYSE:HUBS) has earned a consensus rating of “Buy” from the eighteen brokerages that are covering the company, MarketBeat Ratings reports. Seven analysts have rated the stock with a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $113.27.

A number of research analysts have weighed in on HUBS shares. Zacks Investment Research cut shares of HubSpot from a “hold” rating to a “sell” rating in a research report on Monday, February 19th. UBS Group cut shares of HubSpot from a “buy” rating to a “neutral” rating and set a $123.00 price objective on the stock. in a research report on Thursday, March 8th. Evercore ISI cut shares of HubSpot from an “outperform” rating to an “in-line” rating and set a $90.00 price objective on the stock. in a research report on Monday, March 12th. They noted that the move was a valuation call. ValuEngine upgraded shares of HubSpot from a “hold” rating to a “buy” rating in a research report on Monday, April 2nd. Finally, Bank of America boosted their price objective on shares of HubSpot from $115.00 to $130.00 and gave the company a “buy” rating in a research report on Wednesday, April 18th.

Top 10 Stocks To Own For 2019: Cresud S.A.C.I.F. y A.(CRESY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    News coverage about Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) has trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cresud S.A.C.I.F. y A. earned a daily sentiment score of 0.18 on Accern’s scale. Accern also assigned news stories about the company an impact score of 47.6414670877177 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Shane Hupp]

    Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) saw a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 294,367 shares, a decline of 44.8% from the April 30th total of 533,376 shares. Based on an average daily volume of 179,726 shares, the days-to-cover ratio is presently 1.6 days.

Top 10 Stocks To Own For 2019: Xenon Pharmaceuticals Inc.(XENE)

Advisors’ Opinion:

  • [By Alexander Bird]

    Here are last week’s top-performing penny stocks:

    Penny Stock Current Share Price Last Week’s Gain
    Ambow Education Holdings Ltd. (NYSE: AMBO) $5.70 77.11%
    Nano Dimension (Nasdaq: NNDM) $2.61 75.11%
    Destination Maternity Corp. (Nasdaq: DEST) $5.79 71.84%
    CLPS Inc. (Nasdaq: CLPS) $9.72 71.15%
    NII Holdings Inc. (Nasdaq: NIHD) $3.20 56.33%
    Viveve Medical Inc. (Nasdaq: VIVE) $3.78 51.98%
    Galectin Therapeutics Inc. (Nasdaq: GALT) $9.18 41.82%
    Apricus Biosciences Inc. (Nasdaq: APRI) $0.36 34.70%
    Polymet Mining Corp. (NYSE: PLM) $1.01 31.13%
    Xenon Pharmaceuticals Inc. (Nasdaq: XENE) $8.20 28.46%

    Many investors struggle with finding stocks with this sort of breakout potential because they don’t know where to look.

  • [By Chris Lange]

    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares saw a handy gain on Tuesday after the firm announced positive data from a couple of its trials. Specifically, Xenon presented data from its XEN901 Phase 1 clinical trial and from its XEN1101 Phase 1 clinical trial at the Eilat Conference on New Antiepileptic Drugs and Devices in Madrid, Spain.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
    LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
    MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
    Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
    Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
    Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
    PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
    Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
    Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
    Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Ethan Ryder]

    Xenon Pharmaceuticals Inc (NASDAQ:XENE) traded up 2.7% during mid-day trading on Monday . The stock traded as high as $11.00 and last traded at $9.60. 1,488 shares changed hands during trading, a decline of 100% from the average session volume of 400,794 shares. The stock had previously closed at $9.35.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Xenon Pharmaceuticals (XENE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Own For 2019: Intec Pharma Ltd.(NTEC)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Intec Pharma (NTEC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Media stories about Intec Pharma (NASDAQ:NTEC) have been trending somewhat positive on Wednesday, according to Accern Sentiment. The research group ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Intec Pharma earned a coverage optimism score of 0.18 on Accern’s scale. Accern also assigned news stories about the biotechnology company an impact score of 45.6707447165993 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Joseph Griffin]

    Intec Pharma (NASDAQ:NTEC) has been assigned a $15.00 target price by Oppenheimer in a research note issued to investors on Wednesday. The firm presently has a “buy” rating on the biotechnology company’s stock. Oppenheimer’s price objective would indicate a potential upside of 185.71% from the company’s current price.

  • [By Max Byerly]

    Headlines about Intec Pharma (NASDAQ:NTEC) have trended somewhat positive recently, Accern Sentiment reports. Accern scores the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Intec Pharma earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news coverage about the biotechnology company an impact score of 45.4513319646459 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Top 10 Stocks To Own For 2019: MYR Group Inc.(MYRG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on MYR Group (MYRG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday.
    Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each.
    Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75.
    STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday.
    YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings.
    MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings.
    Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share.
    Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings.
    The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings.
    Ca
  • [By Max Byerly]

    News headlines about MYR Group (NASDAQ:MYRG) have been trending somewhat positive on Thursday, Accern reports. Accern scores the sentiment of press coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. MYR Group earned a media sentiment score of 0.05 on Accern’s scale. Accern also assigned media coverage about the utilities provider an impact score of 46.210188030524 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on MYR Group (MYRG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Shares of MYR Group, Inc. (NASDAQ:MYRG) have been given a consensus recommendation of “Hold” by the ten analysts that are currently covering the company, Marketbeat.com reports. Six analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $35.83.

Top 10 Stocks To Own For 2019: Legacy Reserves LP(LGCY)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market is a market of individual stocks, though, and even with major benchmarks having stalled, some companies are enjoying unparalleled success. In particular, TransEnterix (NYSEMKT:TRXC), BeiGene (NASDAQ:BGNE), and Legacy Resources LP (NASDAQ:LGCY) have all quadrupled in price in just a single year, and investors who are just finding out about them want to know if there are further gains in their futures. There aren’t any sure things in investing, but the prospects that all three of these companies have could fuel additional advances if things go right for them.

  • [By Shane Hupp]

    Legacy Reserves LP (NASDAQ:LGCY) hit a new 52-week high and low on Tuesday . The stock traded as low as $8.74 and last traded at $8.63, with a volume of 42189 shares. The stock had previously closed at $8.36.

  • [By Jason Hall]

    Shares of Texas-based independent oil producerLegacy Reserves LP(NASDAQ:LGCY) finished regular trading down by 15.9% on May 22. To add further frustration for some investors, the drop wasn’t tied to any news for the partnership specifically, or for oil producers in general. As a matter of fact, oil prices climbed on the day, breaching the $80 per-barrel mark briefly before receding a little. Brent crude futures finished the day at $79.49, the highest price for crude oil in more than three years, while West Texas Intermediate — or WTI — futures were relatively flat at around $72 per barrel on the day.

  • [By Money Morning News Team]

    And after taking a look at our 10 top penny stocks to watch, we’ll show you a small-cap stock that just signed a deal with Facebook Inc. (Nasdaq:FB)…

    Penny Stock Current Share Price Law Week’s Gain
    Blink Charging Co. (Nasdaq: BLNK) $6.00 288.51%
    Enterprise GP Holdings LP (NYSE: EPE) $2.94 44.00%
    Opko Health Inc. (Nasdaq: OPK) $4.79 43.49%
    MYnd Analytics Inc. (Nasdaq: MYND) $3.15 38.84%
    Arrowhead Pharmaceuticals Inc. (Nasdaq: ARWR) $0.52 37.80%
    Mid-Con Energy Partners LP (Nasdaq: MCEP) $2.08 36.81%
    VAALCO Energy (NYSE: EGY) $1.49 36.04%
    Cel-Sci Corp. (NYSE: CVM) $3.16 35.04%
    WideOpenWest Inc. (NYSE: WOW) $8.41 34.52%
    Legacy Reserves LP (Nasdaq: LGCY) $8.43 33.61%

    While these gains are certainly exciting, it’s important to recognize that investing in penny stocks is also a risky investment strategy.

Top 10 Stocks To Own For 2019: Applied Industrial Technologies, Inc.(AIT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Applied Industrial Technologies (NYSE:AIT)’s share price reached a new 52-week high during mid-day trading on Friday . The company traded as high as $76.38 and last traded at $76.35, with a volume of 2108 shares traded. The stock had previously closed at $75.50.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Applied Industrial Technologies (AIT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    AICHAIN (CURRENCY:AIT) traded up 5.1% against the U.S. dollar during the 24 hour period ending at 0:00 AM ET on May 29th. AICHAIN has a total market cap of $13.40 million and approximately $1.60 million worth of AICHAIN was traded on exchanges in the last 24 hours. During the last week, AICHAIN has traded 13.4% lower against the U.S. dollar. One AICHAIN token can now be bought for approximately $0.0250 or 0.00000335 BTC on cryptocurrency exchanges including CoinEgg, BCEX, Allcoin and BigONE.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Applied Industrial Technologies (AIT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Own For 2019: Franklin Resources, Inc.(BEN)

Advisors’ Opinion:

  • [By Max Byerly]

    Millennium Management LLC lessened its holdings in Franklin Resources, Inc. (NYSE:BEN) by 23.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,028,586 shares of the closed-end fund’s stock after selling 308,833 shares during the quarter. Millennium Management LLC owned 0.19% of Franklin Resources worth $35,671,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Franklin Templeton Investments (BEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    State of Alaska Department of Revenue increased its stake in shares of Franklin Resources, Inc. (NYSE:BEN) by 14.9% in the second quarter, HoldingsChannel reports. The firm owned 70,018 shares of the closed-end fund’s stock after buying an additional 9,084 shares during the quarter. State of Alaska Department of Revenue’s holdings in Franklin Resources were worth $2,243,000 at the end of the most recent reporting period.

  • [By Paul Ausick]

    Franklin Resources Inc. (NYSE: BEN) traded down about 2% Wednesday to post a new 52-week low of $32.41 after closing Tuesday at $33.09. The stock’s 52-week high is $47.65. Volume was about equal to the daily average of around 3.6 million shares. The company had no specific news Wednesday.

  • [By Stephan Byrd]

    Press coverage about Franklin Templeton Investments (NYSE:BEN) has trended positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Franklin Templeton Investments earned a coverage optimism score of 0.42 on Accern’s scale. Accern also assigned press coverage about the closed-end fund an impact score of 46.7483317362535 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Top 10 Stocks To Own For 2019: CDK Global, Inc.(CDK)

Advisors’ Opinion:

  • [By Shane Hupp]

    Birch Hill Investment Advisors LLC lessened its position in shares of CDK Global Inc (NASDAQ:CDK) by 0.5% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 244,208 shares of the software maker’s stock after selling 1,175 shares during the quarter. CDK Global makes up 1.3% of Birch Hill Investment Advisors LLC’s holdings, making the stock its 29th biggest position. Birch Hill Investment Advisors LLC owned about 0.19% of CDK Global worth $15,468,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    Rikoon Group LLC lifted its stake in shares of CDK Global Inc (NASDAQ:CDK) by 23.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,873 shares of the software maker’s stock after purchasing an additional 1,102 shares during the quarter. Rikoon Group LLC’s holdings in CDK Global were worth $366,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    These are some of the headlines that may have effected Accern Sentiment’s analysis:

    Get CDK Global alerts:

    CDK announces Connected Workshop concept (am-online.com) CDK Global announces new Connected Workshop concept (cardealermagazine.co.uk) Judge: Car dealer software companies can’t delete antitrust claims over monopolization of car dealer data (cookcountyrecord.com) CDK Global (CDK) vs. Ritchie Bros. Auctioneers (RBA) Head-To-Head Survey (americanbankingnews.com) $578.44 Million in Sales Expected for CDK Global (CDK) This Quarter (americanbankingnews.com)

    CDK has been the subject of a number of research analyst reports. Barrington Research restated a “hold” rating on shares of CDK Global in a research note on Monday, March 26th. BidaskClub lowered shares of CDK Global from a “sell” rating to a “strong sell” rating in a research note on Wednesday, February 21st. Zacks Investment Research lowered shares of CDK Global from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 3rd. Morgan Stanley lifted their price target on shares of CDK Global from $76.00 to $77.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 31st. Finally, Wells Fargo restated an “outperform” rating and issued a $80.00 price target (up previously from $75.00) on shares of CDK Global in a research note on Wednesday, January 31st. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $74.80.

  • [By Ethan Ryder]

    CDK Global Inc (NASDAQ:CDK) announced a quarterly dividend on Thursday, June 7th, NASDAQ reports. Shareholders of record on Tuesday, June 19th will be given a dividend of 0.15 per share by the software maker on Friday, June 29th. This represents a $0.60 annualized dividend and a yield of 0.91%. The ex-dividend date of this dividend is Monday, June 18th.

Top 10 Stocks To Own For 2019: Eagle Materials Inc(EXP)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Eagle Materials (EXP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Matthew DiLallo]

    Despite some weather issues during the quarter, Eagle Materials (NYSE:EXP) finished its fiscal year on a positive note and delivered record revenue. That solid finish enabled the diversified materials producer to set full-year records for both sales and earnings. Meanwhile, with a strong balance sheet and some tailwinds at its back, the company sees even better days ahead.

  • [By Shane Hupp]

    Barings LLC reduced its holdings in shares of Eagle Materials (NYSE:EXP) by 12.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 110,475 shares of the construction company’s stock after selling 15,166 shares during the period. Barings LLC owned about 0.23% of Eagle Materials worth $11,384,000 at the end of the most recent reporting period.

Top 10 Stocks To Own For 2019: Progress Software Corporation(PRGS)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    The secret to becoming a millionaire, of course, is getting out in front of a major investment trend before it becomes mainstream. In 2017, it was Bitcoin and cryptocurrencies. But this year, it’s a taboo investment that is creating millionaires all across North America. Tap into the “green rush,” and prepare to become a “Marijuana millionaire.” Learn how to get started right here.

    The Top Stock Market Stories for Wednesday
    U.S. President Donald Trump is facing criticism after threatening to ramp up taxes on Harley-Davidson Inc. (NYSE: HOG). The iconic motorcycle producer said it will move parts of its production overseas in order to avoid tariffs from the European Union. Trump threatened to increase taxes on the firm. “Surprised that Harley-Davidson, of all companies, would be the first to wave the White Flag,” Trump tweeted Tuesday. “I fought hard for them and ultimately they will not pay tariffs selling into the E.U., which has hurt us badly on trade, down $151 Billion. Taxes just a Harley excuse – be patient!” Earlier this month,Microsoft Corp.(Nasdaq:MSFT) launched a $7.5 billion takeover of the web-based hosting service GitHub. The acquisition, orchestrated by Microsoft CEO Satya Nadella, brought out critics who claim that GitHub lacks any real profit potential forMicrosoft stock. Here’s why those critics are wrong… and why MSFT is a buy. Facebook Inc. (Nasdaq: FB) has reversed its policy on cryptocurrency ads. The social media giant says that it will permit marketing from “pre-approved advisers.” According to TechCrunch, the company will still ban ads pushing binary options and initial coin offerings. The report goes on to explain that cryptocurrency scams cost customers more than $500 million in just January and February 2018 alone.
    Four Stocks to Watch Today: ORCL, FB, GOOGL, BA
    Oracle Corp. (NYSE: ORCL) were largely flat despite a strong earnings report after the bell yesterday. The cloud computing giant reported EPS of $0.99

  • [By Shane Hupp]

    Smith Asset Management Group LP cut its holdings in shares of Progress Software (NASDAQ:PRGS) by 45.9% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 61,653 shares of the software maker’s stock after selling 52,380 shares during the period. Smith Asset Management Group LP owned 0.14% of Progress Software worth $2,371,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Ethan Ryder]

    Progress Software (NASDAQ:PRGS) posted its quarterly earnings results on Wednesday. The software maker reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.53 by $0.07, RTT News reports. Progress Software had a net margin of 13.86% and a return on equity of 25.03%. The firm had revenue of $96.10 million for the quarter, compared to analyst estimates of $95.03 million. During the same period in the previous year, the business posted $0.42 earnings per share. Progress Software’s quarterly revenue was up 3.1% on a year-over-year basis. Progress Software updated its Q3 guidance to $0.56-$0.58 EPS and its FY18 guidance to $2.45-$2.50 EPS.

Intec Pharma (NTEC) PT Set at $15.00 by Oppenheimer

Intec Pharma (NASDAQ:NTEC) has been assigned a $15.00 target price by Oppenheimer in a research note issued to investors on Wednesday. The firm presently has a “buy” rating on the biotechnology company’s stock. Oppenheimer’s price objective would indicate a potential upside of 185.71% from the company’s current price.

Other research analysts also recently issued research reports about the company. Zacks Investment Research downgraded Intec Pharma from a “buy” rating to a “hold” rating in a report on Wednesday, January 10th. Maxim Group increased their target price on Intec Pharma from $8.00 to $12.00 and gave the stock a “buy” rating in a report on Monday, March 26th. HC Wainwright started coverage on Intec Pharma in a report on Monday, February 26th. They set a “buy” rating on the stock. Finally, Ladenburg Thalmann started coverage on Intec Pharma in a report on Wednesday, February 28th. They set a “buy” rating on the stock. Two investment analysts have rated the stock with a sell rating and six have issued a buy rating to the company’s stock. Intec Pharma presently has a consensus rating of “Buy” and an average price target of $12.67.

How to Become a New Pot Stock Millionaire

Shares of NTEC opened at $5.25 on Wednesday. The stock has a market capitalization of $166.88, a P/E ratio of -3.18 and a beta of 1.26. Intec Pharma has a one year low of $4.80 and a one year high of $9.80.

Intec Pharma (NASDAQ:NTEC) last issued its quarterly earnings results on Friday, March 9th. The biotechnology company reported ($0.39) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.19). equities analysts forecast that Intec Pharma will post -1.15 EPS for the current fiscal year.

A number of large investors have recently added to or reduced their stakes in NTEC. Deutsche Bank AG lifted its holdings in Intec Pharma by 59.2% during the 4th quarter. Deutsche Bank AG now owns 115,217 shares of the biotechnology company’s stock worth $593,000 after buying an additional 42,867 shares during the last quarter. Renaissance Technologies LLC lifted its holdings in Intec Pharma by 66.0% during the 4th quarter. Renaissance Technologies LLC now owns 133,500 shares of the biotechnology company’s stock worth $688,000 after buying an additional 53,100 shares during the last quarter. Pura Vida Investments LLC bought a new position in Intec Pharma during the 3rd quarter worth approximately $895,000. Millennium Management LLC bought a new position in Intec Pharma during the 4th quarter worth approximately $1,392,000. Finally, Meitav Dash Investments Ltd. acquired a new stake in shares of Intec Pharma during the 4th quarter worth approximately $8,607,000. 41.39% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The original version of this piece of content can be viewed at www.tickerreport.com/banking-finance/3350616/intec-pharma-ntec-pt-set-at-15-00-by-oppenheimer.html.

Intec Pharma Company Profile

Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism.

Analyst Recommendations for Intec Pharma (NASDAQ:NTEC)

Top 10 Safest Stocks For 2019

Kimberly-Clark Corp. (NYSE:KMB) has provided investors with reliable income increases for decades.

In fact, the company is one of the 51 Dividend Aristocrats, which can all be seen here.

Kimberly-Clark pays one of the safest dividends in the market, yields close to 3%, offers mid-single-digit payout growth and sells recession-resistant products.

All of these investment qualities are appealing for retired investors living on dividends.

Like many other large consumer brand multinationals however, Kimberly-Clark is battling foreign currency headwinds, slower growth in developed markets and an evolving competitive landscape.

Let’s take a closer look at Kimberly-Clark to see why it deserves to be a core position in our Top 20 Dividend Stocks portfolio.

Business overview

Kimberly-Clark has been in business since 1928 and has grown into one of the largest global manufacturers of various tissue and hygiene products.

Top 10 Safest Stocks For 2019: Rada Electronics Industries Limited(RADA)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, technology shares fell 0.12 percent. Meanwhile, top losers in the sector included Himax Technologies, Inc. (ADR) (NASDAQ: HIMX), down 6 percent, and RADA Electronic Ind. Ltd. (NASDAQ: RADA) down 5 percent.

Top 10 Safest Stocks For 2019: Bank of Marin Bancorp(BMRC)

Advisors’ Opinion:

  • [By Christopher Flens-Batina]

    Bank of Marin (NASDAQ:BMRC) has shot up about 40% in value in the past 2 months. Low expenses are one of the reasons for the recent growth, and free checkingaccounts are a big part of this.

  • [By Lisa Levin]

    Monday afternoon, the financial sector proved to be a source of strength for the market. Leading the sector was strength from Bank of Marin Bancorp (NASDAQ: BMRC) and BankUnited (NYSE: BKU).

Top 10 Safest Stocks For 2019: AmerisourceBergen Corporation (Holding Co)(ABC)

Advisors’ Opinion:

  • [By Ben Levisohn]

    AmerisourceBergen (ABC) sprinted to the top of the S&P 500 after releasing Street-beating earnings this morning.

    Getty Images

    Shares of AmerisourceBergen jumped 8.8% to $$75.96 today, while the S&P 500 dropped fell 0.7% to 2,097.94.

    Leerink’s David Larsen and Matt Dellelo traces today’s big gain to Amerisource’s big drop following McKesson’s (MCK) earnings last week:

    This morningAmerisourceBergen reported adjusted EPS of $1.30, which was well ahead of Leerink/consensus of $1.22/$1.22. The quality of the beat appears decent, with some pressure in gross margin, completely offset by lower SG&A costs. Given the dramatic reduction in guidance provided byMcKesson (MP), investors had been very cautious heading into the quarter. We are pleased to see that F2017 EPS guidance of $5.63-$5.88 brackets Leerink/consensus estimates of $5.85/$5.82. Brand inflation is now expected to be in the +7-9% range from 10% previously, and F2017 is expected to be back-half loaded. Our first impression of the quarter is that the print and guide are good and there will likely be a relief rally in the shares.

    AmerisourceBergen’s market capitalization rose to $18.1 billion from $16.6 billion yesterday.

Top 10 Safest Stocks For 2019: James River Group Holdings, Ltd.(JRVR)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of PhiloSmith Capital Corp’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=PhiloSmith+Capital+Corp

    These are the top 5 holdings of PhiloSmith Capital CorpPrimerica Inc (PRI) – 122,700 shares, 7.85% of the total portfolio. Chubb Ltd (CB) – 61,750 shares, 7.59% of the total portfolio. Reinsurance Group of America Inc (RGA) – 65,550 shares, 7.11% of the total portfolio. Brown & Brown Inc (BRO) – 193,225 shares, 7.03% of the total portfolio. Arthur J. Gallagher & Co (AJG) – 143,725 shares, 6.95% of the to

Top 10 Safest Stocks For 2019: Ashford Hospitality Trust Inc(AHT)

Advisors’ Opinion:

  • [By Lisa Levin] Related AHT 25 Biggest Mid-Day Gainers For Friday Mid-Day Market Update: Hortonworks Drops Following Weak Results; Freshpet Shares Spike Higher Ashford Hospitality Trust's (AHT) CEO Montgomery Bennet on Q2 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related NEWS Mid-Morning Market Update: Markets Open Higher; Micron To Lower Jobs Mid-Morning Market Update: Markets Open Lower; Broadcom Profit Beats Expectations NewStar Financial's (NEWS) CEO Tim Conway on Q2 2016 Results – Earnings Call Transcript (Seeking Alpha)

     

Top 10 Safest Stocks For 2019: Shenandoah Telecommunications Co(SHEN)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, telecommunications services shares fell 0.45 percent. Meanwhile, top losers in the sector included Shenandoah Telecommunications Company (NASDAQ: SHEN), down 3 percent, and TIM Participacoes SA (ADR) (NYSE: TSU) down 2 percent.

  • [By WWW.THESTREET.COM]

    Cramer said that Shenandoah Telecommunications (SHEN) is expensive at 60 times earnings, and without a dividend, he also took a pass on that one.

    Finally, Cramer said Hudson Technologies (HDSN) was a great stock to own in 2016, when shares soared 170%, but this year, he cannot recommend this high-flying refrigeration company.

  • [By Lisa Levin]

    In trading on Friday, telecommunications services shares fell by 0.99 percent. Meanwhile, top losers in the sector included Chunghwa Telecom Co., Ltd (ADR) (NYSE: CHT), down 3 percent, and Shenandoah Telecommunications Company (NASDAQ: SHEN), down 4 percent.

Top 10 Safest Stocks For 2019: Greenlight Capital Re Ltd.(GLRE)

Advisors’ Opinion:

  • [By Jim Robertson]

    Note that hedge fund mogul David Einhorn has been a director ofthe predecessor company since May 2006. Mr. Einhorn co-founded, and has served as the President of, Greenlight Capital, Inc., since January 1996. Funds managed by Greenlight are some ofthe Companys principal stockholders. Since July 2004, Mr. Einhorn has served as Chairman of the Board of Greenlight Capital Re, Ltd (Nasdaq: GLRE).

Top 10 Safest Stocks For 2019: Concho Resources Inc.(CXO)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Rising acreage prices are causing Permian peers concern that the market is getting too hot. For example, Concho Resources (NYSE:CXO) recently said that it was having difficulty finding a good value in Permian land deals. That’s saying a lot for a company that completed several deals over the past year, including paying $1.625 billion for 40,000 net acres last August, or more than $40,000 per acre. However, with recent deals in the mid-$40,000s per acre, and up to as high as $58,500 per acre, buyers like Concho are growing cautious, which suggests land values might be topping out.

  • [By Ben Levisohn]

    Large Caps. Our E&P coverage is pricing in $61/bbl WTI and $3.30 gas, and with a lower crude forecast the group is looking less compelling. We argue names that continue to demonstrate resource improvement at the low-end of the cost curve, namely in the Permian and STACK remain attractive, such as Concho Resources (CXO), Devon Energy (DVN), Newfield Exploration (NFX) and Pioneer Natural Resources (PXD). Noble (NBL) remains a compelling value, though has yet to commit to an accelerated US onshore drilling program.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Concho Resources Inc. (NYSE: CXO) which traded down about 9% at $143.15. The stocks 52-week range is $106.73 to $162.91. Volume was 11.8 million compared to the daily average volume of 1.3 million.

  • [By Paul Ausick]

    Concho Resources Inc. (NYSE: CXO) is also rated a Hold with a higher price target of $150. For 2017, Jefferies raised its EPS estimate from $0.33 to $1.32, and for 2018 the estimate was lifted from $2.91 to $3.50. The stock closed at $132.41 on Friday, in a 52-week range of $94.26 to $147.55, and the consensus 12-month target is $167.46.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Monday was Concho Resources Inc. (NYSE: CXO) which traded down about 7% at $140.01. The stocks 52-week range is $106.73 to $162.91. Volume was about 3 million compared to the daily average volume of 1.5 million.

  • [By Ben Levisohn]

    Lear also sees strong “upside potential” forConcho Resources (CXO), Pioneer Natural Resources (PXD) and Newfield Exploration (NFX) as well performance improves in the Permian/STACK, and also writes positively on Devon Energy (DVN).

Top 10 Safest Stocks For 2019: Anavex Life Sciences Corp.(AVXL)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Anavex Life Sciences (OTCQX:AVXL) is down ~40% since Amit Ghate said it would trade substantially lower in an interview with the PRO Weekly Digest in June (see his update comment).

  • [By WWW.MONEYSHOW.COM]

    The lead drug from Anavex Life Sciences (AVXL) — called Anavex 2-73 — has just reported very promising phase 2a results in Alzheimer’s patients at the annual CTAD conference.

Top 10 Safest Stocks For 2019: Intec Pharma Ltd.(NTEC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Intec Pharma Ltd (NASDAQ: NTEC) shares dropped 25 percent to $5.57. Intec Pharma reported a Q3 loss of $0.29 per share.

    Shares of Diplomat Pharmacy Inc (NYSE: DPLO) were down 23 percent to $14.71. Diplomat Pharmacy agreed to buy LDI Integrated Pharmacy Services. Baird downgraded Diplomat Pharmacy from Outperform to Neutral.

  • [By Lisa Levin]

    Intec Pharma Ltd (NASDAQ: NTEC) shares were also up, gaining 14 percent to $5.53. Intec Pharma priced 10.6 million share offering at $4.70 per share.